Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhomboid intercostal block with different ropivacaine concentrations in VATS
ChiCTR2100046254Phase 4Recruiting
- Sponsor
- Jiaxing Second Hospital
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in bronchial carcinoma and postoperative pain (4 arms), sponsored by Jiaxing Second Hospital. Primary endpoints: Numerical Rating Scale pain score (NRS), Opioid use and 1 more. Started May 2021; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
bronchial carcinomapostoperative pain
Beyond the preview
Go deeper on ChiCTR2100046254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046254.